Tarsus Pharmaceuticals (TARS) Prepaid Assets (2019 - 2026)

Tarsus Pharmaceuticals' Prepaid Assets history runs 8 years deep, the most recent figure standing at $26.7 million for Q1 2026.

• In Q1 2026, Prepaid Assets rose 345.37% year-over-year to $26.7 million; the TTM figure through Mar 2026 stood at $26.7 million (up 345.37% YoY), while the FY2025 annual figure was $13.5 million, down 8.03% from the prior year.
• Prepaid Assets was $26.7 million for Q1 2026 at Tarsus Pharmaceuticals, up from $13.5 million in the prior quarter.
• In the past five years, Prepaid Assets ranged from a high of $29.2 million in Q2 2025 to a low of $3.1 million in Q1 2022.
• Historically, Prepaid Assets has averaged $10.0 million across 5 years, with a median of $6.0 million in 2023.
• Biggest YoY gain for Prepaid Assets was 388.5% in 2025; the steepest drop was 11.82% in 2025.
• A 5-year view of Prepaid Assets shows it stood at $4.8 million in 2022, then jumped by 65.05% to $7.9 million in 2023, then surged by 86.2% to $14.6 million in 2024, then decreased by 8.03% to $13.5 million in 2025, then surged by 98.31% to $26.7 million in 2026.
• The last three Prepaid Assets figures came in at $26.7 million (Q1 2026), $13.5 million (Q4 2025), and $21.7 million (Q3 2025), per Business Quant data.